82 filings
Page 2 of 5
8-K
z4vat8
11 May 23
Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates
8:15am
8-K
xfzfuw5e0qly1
11 Apr 23
Other Events
9:15am
8-K
btuo 428a
28 Mar 23
Other Events
8:01am
8-K
lei46btktmc6jsh
8 Mar 23
Entry into a Material Definitive Agreement
8:00am
8-K
gtuvdpqnfi0gru5g
10 Feb 23
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates
8:15am
8-K
awvlk16r457rq1dbzbk
9 Jan 23
Results of Operations and Financial Condition
8:00am
8-K
rrb7ft5ew9j4h hl5
10 Nov 22
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates
8:15am
EFFECT
c7wi7xclswqlzc2b316
10 Nov 22
Notice of effectiveness
12:00am
CORRESP
bfsfr 0cb2jjn0i1t
8 Nov 22
Correspondence with SEC
12:00am
UPLOAD
6wv9rio4
8 Nov 22
Letter from SEC
12:00am
8-K
36wir56lk4
28 Oct 22
Submission of Matters to a Vote of Security Holders
4:05pm
DEFR14A
90h1m07c
25 Oct 22
Revised proxy
5:27pm
8-K
nu5w4o1i4mz04k5njvk
13 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
D
lqc4 yg1fnot
7 Oct 22
$16.19 mm in equity / options / securities to be acquired, sold $6.65 mm, 5 investors
5:32pm
8-K
tflfukwg
29 Sep 22
Anebulo Pharmaceuticals Announces $6.6 million Private Placement Financing
4:05pm
8-K
ck7y5tsgc71lp25 3e
26 Sep 22
Regulation FD Disclosure
8:00am